"Centre médical pour consultations"

During the past decade, CHIREC Edith Cavell conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CHIREC Edith Cavell" are "Anemia" (1 trials), "Malignant Melanoma" (1 trials) and "Metastatic Melanoma" (1 trials). Many other conditions were trialed in "CHIREC Edith Cavell" in a lesser frequency.

Most popular intervention types in "CHIREC Edith Cavell" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cobimetinib" (1 trials), "Vemurafenib" (1 trials) and "methoxy polyethylene glycol-epoetin beta" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHIREC Edith Cavell" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CHIREC Edith Cavell". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CHIREC Edith Cavell, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHIREC Edith Cavell, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".